Publications by authors named "F Lenoir"

Claim this Profile
D
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models.
Guillaume Dutheuil, Killian Oukoloff, Julien Korac, François Lenoir, Mohamed El Bousmaqui

J Med Chem· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Throughput Screen for Inhibitors of Virulence Using a Co-Culture Surrogate Host Model.
Angela L Woods, David Parker, Meir M Glick, Yunshan Peng, Francois Lenoir

ACS Omega· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Thiazolylamide-based free fatty-acid 2 receptor agonists: Discovery, lead optimization and demonstration of off-target effect in a diabetes model.
Hamid R Hoveyda, Graeme L Fraser, Ludivine Zoute, Guillaume Dutheuil, Didier Schils, François Lenoir

Bioorg Med Chem· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Properties of a Potent Inhibitor of Pseudomonas aeruginosa Deacetylase LpxC.
Grazia Piizzi, David T Parker, Yunshan Peng, Markus Dobler, Anup Patnaik, Francois Lenoir

J Med Chem· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
Ying-Nan P Chen, Matthew J LaMarche, Ho Man Chan, Peter Fekkes, Jorge Garcia-Fortanet, Francois Lenoir

Nature· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis